Search Results

Here is how founders can start regaining strategic control: ✅ Define clear decision rights : Who has Are we still executing the right plan, or just the most recent one? 👉 By this point, you might be asking yourself: how much of our strategy is truly founder-led? Here are five strategic questions every biotech founder should revisit regularly: 1️⃣ Who signs off on But never direction. ✅ Founders who embrace strategic governance as a discipline are the ones who stay

Positioning Is the Hidden Lever in Biotech Hiring When biotech founders struggle to attract top talent isn’t an admin task — it’s a strategic growth lever. Examples biotech founders can offer: Chance to lead research with real-world impact Equity participation The founder who treats recruitment like marketing — targeted, proactive, and relentless — is the one At Timeline Strategy , Attila works with biotech founders to bring clarity, focus, and execution to whatever

Most founders think their company’s future is shaped by the visible: Revenue numbers Market size Competitors And yet, too many founders behave as if time were infinite. Emotions — The Invisible Factor That Silently Steers Every Decision Every founder likes to think they My strategy consultations are designed to help founders spot cracks in these invisible drivers before Together, we’ll map out where cashflow, time, and emotions are holding you back — and create a plan to

👉 Investors are questioning how this team will decide when the next inflection point does not go as planned founder bottlenecks that already exist inside the company.   How to Reframe Biotech Fundraising as a Strategic System 👉 Founders who regain control in biotech fundraising It's strategic. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not

journey from startup to scale-up is filled with unique biotech scale-up challenges that often catch founders founder or executive aiming to turn early promise into lasting impact. 👉 In this article, we will break Understanding the most common biotech scale-up challenges can help founders and teams prepare for what Many founders believe that as their company grows, operations will become easier and more predictable Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity,

If you’re a biotech founder, overwhelmed COO, or scientist-turned-CEO, ask yourself: Does your average Block time daily to think, plan, and synthesize. Founders who don’t carve out strategic space lose control of their company’s direction . 4. Calculate the Cost of Each Activity Multiply the time spent on each activity by your hourly rate as a founder Need help building a weekly structure that aligns with your actual job as CEO or founder?

Within 18 months, they collapsed under cash burn and operational chaos.

For most founders, the dream isn’t just to build a successful company it’s to create a self-sustaining step is acknowledging that founder dependency is a liability, not a badge of honor. it is a mindset shift that gives you true freedom as a founder. It’s strategic. Attila runs focused strategy consultations for SME founders who are ready to lead with clarity, not just

Think of it this way : Two companies were founded in the same year with the same scientific basis. Build the Continuous Experiment Engine— or stay stuck playing biotech roulette while your competitors

It often shows up in capable teams led by thoughtful founders who care deeply about getting things right Strategic Takeaway - Q1 rewards clarity 👉 Q1 rewards clarity . flexibility ever will . ✅ In Q1, choosing deliberately is one of the strongest leadership moves a biotech founder It's strategic. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not

The scaling cliff is real: a company that thrived at 20 people collapses under the weight of 80. Signal 1: The Bottleneck is No Longer Science Most biotech founders assume the lab is the constraint.